Cite
HARVARD Citation
Kim, S. et al. (2019). Less frequent rituximab retreatment maintains remission of neuromyelitis optica spectrum disorder, following long-term rituximab treatment. Journal of neurology, neurosurgery and psychiatry. 90 (4), pp. 486-487. [Online].